Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001209191-23-050173

Chief Business Officer sold 1,261 shares at $9.41 ($11,866)

From the SEC's structured data for this filing

Trades in this filing

McNeill Jonathan · Chief Business Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-09-18 Sale : show line 1 in the form −1,261 $9.41 $11,866 60,605 D
Open-market sales · 1,261 sh · avg $9.41 · $11,866
Loading xslF345X05/doc4.xml…